These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 22044675

  • 41. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D, Oral I, Lacnák B, Juráková R, Horalík D, Adamovská S, Prosková J, Hrabovská I, Ozanová G.
    Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579
    [Abstract] [Full Text] [Related]

  • 42. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B, Lindbäck J, Jernberg T, Johnston N, Stridsberg M, Venge P, Wallentin L.
    J Am Coll Cardiol; 2005 Feb 15; 45(4):533-41. PubMed ID: 15708700
    [Abstract] [Full Text] [Related]

  • 43. Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes.
    Ndrepepa G, Braun S, Schulz S, Byrne RA, Pache J, Mehilli J, Schömig A, Kastrati A.
    Clin Chim Acta; 2011 Jul 15; 412(15-16):1350-6. PubMed ID: 21497154
    [Abstract] [Full Text] [Related]

  • 44. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
    Gill D, Seidler T, Troughton RW, Yandle TG, Frampton CM, Richards M, Lainchbury JG, Nicholls G.
    Clin Sci (Lond); 2004 Feb 15; 106(2):135-9. PubMed ID: 12974669
    [Abstract] [Full Text] [Related]

  • 45. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G, Corrado E, Mulè MC, Augugliaro S, Cucchiara A, Novo G, Amoroso G, Assennato P, Hoffmann E, Vitale F, Novo S.
    Coron Artery Dis; 2009 May 15; 20(3):225-9. PubMed ID: 19387249
    [Abstract] [Full Text] [Related]

  • 46. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
    Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, Stansborough J, Beltrame JF, Selvanayagam JB, Zeitz CJ, Struthers AD, Frenneaux MP, Horowitz JD.
    Am J Cardiol; 2011 Nov 01; 108(9):1316-21. PubMed ID: 21871590
    [Abstract] [Full Text] [Related]

  • 47. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.
    Am Heart J; 2012 May 01; 163(5):821-8. PubMed ID: 22607860
    [Abstract] [Full Text] [Related]

  • 48. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.
    Clin Biochem; 2006 Jun 01; 39(6):640-5. PubMed ID: 16516185
    [Abstract] [Full Text] [Related]

  • 49. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
    Abroug F, Ouanes-Besbes L, Nciri N, Sellami N, Addad F, Hamda KB, Amor AB, Najjar MF, Knani J.
    Am J Respir Crit Care Med; 2006 Nov 01; 174(9):990-6. PubMed ID: 16840745
    [Abstract] [Full Text] [Related]

  • 50. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr 01; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 51. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.
    J Vet Cardiol; 2009 May 01; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [Abstract] [Full Text] [Related]

  • 52. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
    Horacek JM, Pudil R, Tichy M, Jebavy L, Zak P, Slovacek L, Maly J.
    Exp Oncol; 2007 Sep 01; 29(3):243-7. PubMed ID: 18004253
    [Abstract] [Full Text] [Related]

  • 53. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Sohn DW, Kim CH, Oh BH, Park YB, Choi YS.
    Int J Cardiol; 2008 Jun 06; 126(3):322-32. PubMed ID: 17544525
    [Abstract] [Full Text] [Related]

  • 54. Simple markers can distinguish Takotsubo cardiomyopathy from ST segment elevation myocardial infarction.
    Budnik M, Kochanowski J, Piatkowski R, Wojtera K, Peller M, Gaska M, Glowacka P, Karolczak P, Ochijewicz D, Opolski G.
    Int J Cardiol; 2016 Sep 15; 219():417-20. PubMed ID: 27367474
    [Abstract] [Full Text] [Related]

  • 55. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
    Chang CL, Robinson SC, Mills GD, Sullivan GD, Karalus NC, McLachlan JD, Hancox RJ.
    Thorax; 2011 Sep 15; 66(9):764-8. PubMed ID: 21474497
    [Abstract] [Full Text] [Related]

  • 56. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.
    De Servi S, Mariani G, Piatti L, Leoncini M, Rubartelli P, Pitì A, Curello S, Galdangelo F, Vandoni P, Rossetti E, Mariani M, Boschetti E, Re G, Loznicker M.
    J Cardiovasc Med (Hagerstown); 2014 Jan 15; 15(1):42-7. PubMed ID: 24492354
    [Abstract] [Full Text] [Related]

  • 57. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A, Lipid Assessment Trial Italian Network (LATIN) Investigators.
    Circulation; 2004 Oct 19; 110(16):2349-54. PubMed ID: 15477419
    [Abstract] [Full Text] [Related]

  • 58. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 59. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.
    Indian Heart J; 2008 Aug 18; 60(6):536-42. PubMed ID: 19276492
    [Abstract] [Full Text] [Related]

  • 60. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA, Adiyaman A, Dambrink JE, Gosselink AM, Kedhi E, Roolvink V, Ottervanger JP, Van't Hof AW.
    Vasc Health Risk Manag; 2016 Aug 18; 12():471-476. PubMed ID: 27920547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.